Huons Ascorbic Acid Injection

Adult administration

As ascorbic acid, 50~1,000 mg is administered subcutaneously, intramuscularly, or intravenously divided into 1 to multiple doses per day. Adjust as appropriate according to age and symptoms.

This medication may contain glass fragments when using ampoule injectables, so it must be handled with extreme care when cutting the container. Extra caution is required, especially when used in children or the elderly. It contains sodium bisulfite, which can cause severe allergic reactions or asthma attacks in patients allergic to sulfites or in asthma patients, so caution is needed. Patients with hypersensitivity to this medication, hyperoxaluria, Mediterranean anemia, gout, cystinuria, and G6PD deficiency should not use it. Additionally, patients with kidney oxalate stones should not be given doses above a certain limit. Side effects may include nausea, vomiting, diarrhea, heartburn, abdominal cramps, fatigue, flushing, headache, and insomnia. High doses may increase the risk of diarrhea and kidney stones, and diuresis may occur. Particularly in patients with G6PD deficiency, hemolysis may occur. Excessive dosing can form stones in the urinary tract, so caution is needed, and injectable forms should be used only when oral administration is difficult and should be switched to oral as soon as possible. This medication may interact with certain drugs, so caution is required when used in conjunction with aspirin, smoking, alcohol, iron supplements, anticonvulsants, oral contraceptives, and some antibiotics. During pregnancy, its safety for the fetus has not been established, so it should only be administered when necessary and high doses should be avoided. Caution is also necessary during breastfeeding, although no significant risks have been reported at regular doses. This medication can affect the results of clinical tests such as urine glucose or hematuria tests, so this should be taken into consideration during testing. In case of overdose, diarrhea and kidney stones may occur, and diuresis may manifest; therefore, the medication should be discontinued immediately and treatment sought if symptoms appear. During injection, there may be pain at the injection site, and only minimal doses should be administered while avoiding nerve areas, with extra caution taken especially in newborns and children. Intravenous injections should be administered slowly to prevent vascular pain or dizziness. This medication should be stored in a dry place, away from direct sunlight, and kept in a secure location out of reach of children. It should also be stored in its original container to prevent quality deterioration or misuse.

Serious side effects

Severe allergic reactions (sulfite anaphylaxis, asthma attacks), hemolysis (in G6PD deficient patients), kidney stones, increased risk of diarrhea and oxalate stones in the kidney.

Mild side effects

Nausea, vomiting, diarrhea, heartburn, abdominal cramps, fatigue, flushing, headache, insomnia, diuresis, temporary mild pain at the injection site, vascular pain, dizziness, fainting.

This medication should be stored in a tightly sealed container that can block light and should be kept at room temperature between 1 and 30 degrees Celsius. This way, the effectiveness of the medication can be maintained for a longer period.

Appearance

Brown ampoule injection containing a colorless to pale yellow liquid

Package unit

2 milliliters x 50 ampoules